Enhanced External Counterpulsation Is Cost‐Effective in Reducing Hospital Costs in Refractory Angina Patients

BACKGROUND: Enhanced external counterpulsation (EECP) is effective in the treatment of refractory angina, a condition suffered by 1.7 million Americans. Declining cardiovascular mortality and appropriate use criteria may further increase this number. HYPOTHESIS: EECP is hypothesized to be cost‐effec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Autores principales: Lawson, William E., Hui, John C.K., Kennard, Elizabeth D., Linnemeier, Georgiann
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley Periodicals, Inc. 2015
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6711070/
https://ncbi.nlm.nih.gov/pubmed/25962616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22395
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares